Mirum Pharmaceuticals, Inc. MIRM Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Mirum Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s cash ratio?
- Mirum Pharmaceuticals, Inc. (MIRM) reported cash ratio of 1× in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s cash ratio changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s cash ratio decreased by 32.9% year-over-year, from 1.4× to 1×.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s cash ratio has grown at a -30.6% compound annual growth rate (CAGR), from 7.7× to 1.2×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.